TrialThe lancet. Diabetes & endocrinology2026

Efficacy and safety of relacorilant for the treatment of patients with Cushing's syndrome (GRACE): a multicentre, phase 3, double-blind, placebo-controlled, randomised-withdrawal study.

Rosario Pivonello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.